Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
Olanzapine treatment resulted in improvements in positive and general psychiatric symptoms, as well as quality of life. Negative symptoms did not change significantly. Though not statistically significant, the postbaseline health-care costs and utilization declined.
Authors
- Sandra M Ambrose
- Brandi L Thomas
- Jeffrey D. Johnson (ORCID: https://orcid.org/0000-0001-7651-6992)
- Marshall E. Cates (ORCID: https://orcid.org/0000-0002-2960-1921)
- Leigh C. Ward (ORCID: https://orcid.org/0000-0003-2378-279X)
- Raela B Williford
- Lori L. Davis (ORCID: https://orcid.org/0000-0002-6098-5986)
Institutions
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-08-12
- DOI
- https://doi.org/10.64719/pb.4292
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00